EUVIMEDEUVIMED entdecken
Crossref

Discontinuation of Antithrombotic Management Following Left Atrial Appendage Occlusion in High Bleeding Risk Patients

Siu-Fung Wong iD, James W McCready, James Cockburn, Christopher Broyd, Timothy Bagnall iD, Sandeep Arunothayaraj, Arionilson Gomes, Andrew Hill, David Hildick-Smith

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Siu-Fung Wong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex, Brighton, UK. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Hemorrhage, Fibrinolytic Agents. Die Arbeit nennt 30 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antithrombotic therapy is required after left atrial appendage occlusion (LAAO) whilst endothelialization of the device occurs. LAAO patients are usually at high bleeding risk and the optimal antithrombotic regimen post‐implantation remains debated.

Aims

We aimed to study the efficacy of using maximum of 6‐month antithrombotic treatment post‐LAAO in high bleeding risk patients with atrial fibrillation.

Methods

Data from patients who had LAAO at our center between 2015 and 2024 were examined. Those who were discharged on a plan of 6 months antithrombotic therapy were included. Incidence of stroke, transient ischaemic attack (TIA), major bleeding or death during follow‐up was measured.

Results

A total of 128 patients met the analysis criteria. One hundred and six (82.8%) patients had a previous major bleeding event with or without oral anticoagulation. Seventy‐eight (60.9%) patients had a previous stroke. The median CHA 2 DS 2 ‐VASc and HAS‐BLED scores were 4 and 3 respectively. Complete closure of the left atrial appendage was achieved in 116 (90.6%) patients with no peri‐device flow. Follow‐up was obtained for 484 patient‐years (median follow‐up time 3.6 years). Post‐procedure, 126 (98.4%) patients had antiplatelet therapy only, for 6 months or less. Stroke or TIA occurred in 5.5% of patients (1.45 per 100 patient‐years)—a 69% reduction compared to the predicted risk. 10.2% of patients suffered from major bleeding (2.69 per 100 patient‐years). 36.7% (9.71 per 100 patient‐years) of patients died.

Conclusion

Complete cessation of antithrombotic treatment 6 months after LAAO was associated with a low incidence of subsequent stroke or TIA in patients at high bleeding risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial AppendageAtrial FibrillationHemorrhageFibrinolytic AgentsStrokeCardiac CatheterizationPlatelet Aggregation InhibitorsHumansMaleFemaleAgedRisk FactorsTime FactorsRisk AssessmentTreatment OutcomeRetrospective StudiesAged, 80 and overIschemic Attack, TransientDrug Administration ScheduleMiddle Aged

Stichwörter der Autor:innen

antithrombotic managementhigh bleeding riskleft atrial appendage occlusion

Substanzen

Fibrinolytic AgentsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, Sussex Cardiac Centre, University Hospitals Sussex, Brighton, UK.
  • St Vincent's Heart Centre, St Vincent's Hospital Melbourne, Melbourne, Australia.
  • Department of Anaesthesia, Royal Sussex County Hospital, Brighton, UK.

ORCID-Profile: Siu-Fung Wong, Timothy Bagnall

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Wong, S. F., McCready, J. W., Cockburn, J., Broyd, C., Bagnall, T., Arunothayaraj, S., Gomes, A., Hill, A., & Hildick-Smith, D. (2025). Discontinuation of Antithrombotic Management Following Left Atrial Appendage Occlusion in High Bleeding Risk Patients. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70014

Vancouver

Wong SF, McCready JW, Cockburn J, Broyd C, Bagnall T, Arunothayaraj S, et al. Discontinuation of Antithrombotic Management Following Left Atrial Appendage Occlusion in High Bleeding Risk Patients. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70014

BibTeX
@article{Wong2025,
  author = {Wong, Siu-Fung and McCready, James W and Cockburn, James and Broyd, Christopher and Bagnall, Timothy and Arunothayaraj, Sandeep and Gomes, Arionilson and Hill, Andrew and Hildick-Smith, David},
  title = {Discontinuation of Antithrombotic Management Following Left Atrial Appendage Occlusion in High Bleeding Risk Patients},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70014}
}
Kostenlos starten →